These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 4147835)

  • 21. Beta-adrenergic blocking agents: substituted phenylalkanolamines. Effect of side-chain length on beta-blocking potency in vitro.
    Fuhrer W; Ostermayer F; Zimmermann M; Meier M; Müller H
    J Med Chem; 1984 Jul; 27(7):831-6. PubMed ID: 6145802
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis of a novel series of (aryloxy)propanolamines: new selective beta 2-blocking agents.
    Carre MC; Youlassani A; Caubere P; Saint-Aubin-Floch A; Blanc M; Advenier C
    J Med Chem; 1984 Jun; 27(6):792-9. PubMed ID: 6145801
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of beta-adrenolytic properties of N,N'-bis-(3-(p-methoxyphenoxy)-2-hydroxypropyl)-ethylenediamine and its N,N'-dimethyl derivative.
    Robak J; Grodzińska L
    Pol J Pharmacol Pharm; 1973; 25(3):253-7. PubMed ID: 4150018
    [No Abstract]   [Full Text] [Related]  

  • 24. Beta-Adrenergic blocking agents. Nitrogen heteroaryl-substituted 2-propanolamines and ethanolamines.
    Meyer RF; Stratton CD; Hastings SG; Corey RM
    J Med Chem; 1973 Oct; 16(10):113-6. PubMed ID: 4147942
    [No Abstract]   [Full Text] [Related]  

  • 25. o-Chlorobenzenesulfonamidic derivatives of (aryloxy)propanolamines as beta-blocking/diuretic agents.
    Cecchetti V; Fravolini A; Schiaffella F; Tabarrini O; Bruni G; Segre G
    J Med Chem; 1993 Jan; 36(1):157-61. PubMed ID: 8093626
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacological properties of an extremely selective beta 1-adrenoceptor antagonist, 2-[4-[3-(tert-Butylamino)-2-hydroxypropoxy] phenyl]-3-methyl-6-methoxy-4(3H)-quinazolinone [+/-)HX-CH 44 BS).
    Daemmgen JW; Engelhardt G; Pelzer H
    Arzneimittelforschung; 1985; 35(1A):383-90. PubMed ID: 2859033
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Structure-activity relationship of phenoxyalkanolamine derivatives with selective beta 1-receptor blocking action].
    Femmer K
    Pharmazie; 1975 Oct; 30(10):638-42. PubMed ID: 687
    [No Abstract]   [Full Text] [Related]  

  • 28. beta-Adrenergic blocking agents. 16. 1-(Acylaminomethyl-, ureidomethyl-, and ureidoethylphenoxy)-3-amino-2-propanols.
    Smith LH
    J Med Chem; 1977 Oct; 20(10):1254-8. PubMed ID: 20502
    [TBL] [Abstract][Full Text] [Related]  

  • 29. beta-Adrenergic blocking agents. alpha- and gamma-methyl(aryloxy)propanolamines.
    Lemke TL; Cramer MB; Adamski SW; Pedone CA; Brooker G
    J Med Chem; 1981 Oct; 24(10):1211-4. PubMed ID: 6120233
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiac action of carazolol and methypranol in comparison with other beta-receptor blockers.
    Bartsch W; Dietmann K; Leinert H; Sponer G
    Arzneimittelforschung; 1977; 27(5):1022-6. PubMed ID: 18157
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacological properties of a new beta-blocking agent (1-isopropylamino-3-(2-methyl-3-nitrophenoxy)-propan-2-ol).
    Michalska Z; Robak J; Kostka-Trabka E; Grodzińska L; Górka Z; Gryglewski R
    Folia Biol (Krakow); 1974; 22(2):217-28. PubMed ID: 4151603
    [No Abstract]   [Full Text] [Related]  

  • 32. 2-(Isoxazolylethenyl)phenoxypropanolamines: a new class of beta-receptor antagonists with antihypertensive activity.
    Franke A; Frickel FF; Gries J; Lenke D; Schlecker R; Thieme PD
    J Med Chem; 1981 Dec; 24(12):1460-4. PubMed ID: 6118439
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [(Arylcarbonyl)oxy]propanolamines. 1. Novel beta-blockers with ultrashort duration of action.
    Kam ST; Matier WL; Mai KX; Barcelon-Yang C; Borgman RJ; O'Donnell JP; Stampfli HF; Sum CY; Anderson WG; Gorczynski RJ
    J Med Chem; 1984 Aug; 27(8):1007-16. PubMed ID: 6146718
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selective beta 2-adrenoceptor antagonists: derivatives of ICI 118,551 and a binary aryloxypropanolamine.
    Nathanson JA; Hunnicutt EJ
    J Pharm Pharmacol; 1988 Nov; 40(11):803-5. PubMed ID: 2907563
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ultra-short-acting beta-adrenergic receptor blocking agents. 1. (Aryloxy)propanolamines containing esters in the nitrogen substituent.
    Erhardt PW; Woo CM; Gorczynski RJ; Anderson WG
    J Med Chem; 1982 Dec; 25(12):1402-7. PubMed ID: 6130153
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The actions of a new beta-adrenoceptor blocking drug, ICI 66082, on the rabbit papillary muscle and on the dog heart.
    Harry JD; Knapp MF; Linden RJ
    Br J Pharmacol; 1974 Jun; 51(2):169-77. PubMed ID: 4155970
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proceedings: Antagonism by ICI 66082 of the effects of electrical stimulation on the right ansa subclavia of the dog.
    Harry JD; Knapp MF; Linden RJ
    Br J Pharmacol; 1974 Mar; 50(3):457P-458P. PubMed ID: 4153012
    [No Abstract]   [Full Text] [Related]  

  • 38. A comparative study of the activity of beta-adrenoceptor antagonists in man.
    Taylor SH; Thadani U; Davidson C; singleton W; Myint S
    Int J Clin Pharmacol Biopharm; 1975 Jul; 12(1-2):305-6. PubMed ID: 240783
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and pharmacological evaluation of novel potential ultrashort-acting beta-blockers.
    Mokrý P; Zemanová M; Csöllei J; Racanská E; Tumová I
    Pharmazie; 2003 Jan; 58(1):18-21. PubMed ID: 12622246
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Further studies regarding the structure activity relationships of beta-adrenoceptor antagonists.
    Bagwell EE; Williams EM
    Br J Pharmacol; 1973 Aug; 48(4):686-92. PubMed ID: 4150921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.